Fiche centre
Beijing GoBroad Hospital
Beijing — China
Essais liés4clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06943937
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| YTS109 cell injection | Lupus | Phase 1 | NCT06943937 | A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus | TERMINATED |
| Prizloncabtagene Autoleucel | SEP | Phase 1/2 | NCT05800977 | ELEVATION — A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma | RECRUITING |
| LBL-047 for Injection | Lupus | Phase 1 | NCT07323173 | A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus | RECRUITING |
| MTM-H-001 Injection | Myasthénie | Non applicable | NCT07593911 | ArchAid-002 — A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases | NOT_YET_RECRUITING |